In a large cohort of young women, drospirenone did not cause a clinically significant increase in risk for hyperkalemia when compared with other progestin-containing OCs. It is however concerning ...

Three associations of EE with a nontestosterone-derived progestin (CPA, chlormadinone acetate and drospirenone) are currently available and will be discussed in the 'Five-year view' section.